SANTHERA PHARMACEUTICALS-REG/ CH1276028821 /
11/14/2024 11:39:54 AM | Chg. -0.02 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
8.41CHF | -0.24% | 62 Turnover: 521.42 |
-Bid Size: - | -Ask Size: - | 105 mill.CHF | - | 1.92 |
Assets
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 0.0000 | .1000 | .4000 | .5000 | 2.2000 | ||||||
Intangible Assets | 4.2000 | 4.2000 | 29.6000 | 26.5000 | 23.6000 | ||||||
Long-Term Investments | .1000 | .1000 | .2000 | .3000 | .7000 | ||||||
Fixed Assets | 4.3000 | 4.4000 | 33.2000 | 28.4000 | 32.2000 | ||||||
Inventories | 0.0000 | 0.0000 | 3.4000 | 7.7000 | 10.1000 | ||||||
Accounts Receivable | 0.0000 | .7000 | 2.1000 | 4.3000 | 5.4000 | ||||||
Cash and Cash Equivalents | 5 | 17.4000 | 76.9000 | 49.8000 | 45.2000 | ||||||
Current Assets | 5.4000 | 18.5000 | 83.9000 | 62.4000 | 77.6000 | ||||||
Total Assets | 9.7000 | 22.9000 | 117.2000 | 90.8000 | 109.8000 |
Liabilities
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | .6000 | 2.2000 | 3.7000 | 4.5000 | 4.7000 | ||||||
Long-term debt | - | - | - | - | 53.1000 | ||||||
Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 53.1000 | ||||||
Provisions | 1 | .9000 | 3.3000 | 5.8000 | 8.5000 | ||||||
Liabilities | 2.6000 | 5.7000 | 10.9000 | 16.4000 | 77.5000 | ||||||
Share Capital | 3.9000 | 5 | 6.3000 | 6.3000 | 6.3000 | ||||||
Total Equity | 7.1000 | 17.2000 | 106.2000 | 74.4000 | 32.3000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 9.7000 | 22.9000 | 117.2000 | 90.8000 | 109.8000 |
Income Statement
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.3000 | 2.6000 | 4.3000 | 19 | 22.9000 | ||||||
Depreciation (total) | - | - | - | .2000 | .3000 | ||||||
Operating Result | -7.3000 | -7.5000 | 3.2000 | -33.1000 | -50.5000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -5.8000 | -7.5000 | 2.9000 | -33.2000 | -51.3000 | ||||||
Income Taxes | 0.0000 | 0.0000 | 3 | -2.2000 | -.2000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -5.8000 | -7.5000 | 5.9000 | -35.4000 | -51.5000 |
Per Share
Cash Flow
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -7 | -6.1000 | -22.4000 | -27.1000 | -39.6000 | ||||||
Cash Flow from Investing Activities | .3000 | -.2000 | -.6000 | -.5000 | -22.2000 | ||||||
Cash Flow from Financing | -.5000 | 18.7000 | 82.6000 | .6000 | 57.1000 | ||||||
Decrease / Increase in Cash | -7.2000 | 12.4000 | 59.4000 | -27 | -4.6000 | ||||||
Employees | 17 | 15 | 59 | 80 | 112 |